Study identifier:SD-037-0684
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
On the bronchodilating effect of inhaled RR- and SS-formoterol compared with the bronchodilating effect of inhaled RR,SS- formoterol
asthma
Phase 2
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|